Glick Gary D sold ODTX
May 11, 2026 · Form 4 insider transaction
Glick Gary D sold 166,116 shares of Odyssey Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
166,116
Price
N/A
Total value
N/A
InsiderGlick Gary D
RoleOfficer, Director
SecuritySeries D Convertible Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateMay 11, 2026
Filing dateMay 11, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration.; Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering.